Over the past 12 months, 0 insiders at Theseus Pharmaceuticals, Inc. filed 0 open-market SEC Form 4 transactions on THRX: 0 purchases worth $0 and 0 sales worth $0. Insiders have been mixed over this period. The most recent filing was on .
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 17, 23 | Foresite Capital Opportunity Management V, LlcTenPercentOwner | BUY | 523.5K | $2.97 | $1.6M |
| Jul 17, 23 | Carl L GordonDirector,TenPercentOwner | BUY | 328.5K | $3.05 | $1.0M |
| Jul 17, 23 | Orbimed Advisors LlcDirector,TenPercentOwner | BUY | 328.5K | $3.05 | $1.0M |
| Dec 30, 22 | Donald J Hayden JrDirector | BUY | 9.9K | $5.00 | $50K |
| Dec 29, 22 | Foresite Capital Opportunity Management V, LlcTenPercentOwner | BUY | 250.0K | $5.00 | $1.3M |
| Dec 29, 22 | Donald J Hayden JrDirector | BUY | 100 | $5.00 | $500 |
| Nov 30, 22 | Bradford D. DahmsChief Financial Officer | BUY | 1.5K | $6.66 | $10K |
| Nov 11, 22 | Timothy P ClacksonPresident and CEO | BUY | 2.5K | $6.80 | $17K |
| Nov 7, 22 | Carl L GordonDirector,TenPercentOwner | BUY | 192.0K | $5.21 | $1.0M |
| Nov 7, 22 | Orbimed Genesis Gp LlcDirector,TenPercentOwner | BUY | 192.0K | $5.21 | $1.0M |
| Jan 21, 22 | Carl L GordonDirector,TenPercentOwner | BUY | 111.9K | $9.97 | $1.1M |
| Jan 21, 22 | Orbimed Capital Gp VII LlcDirector,TenPercentOwner | BUY | 111.9K | $9.97 | $1.1M |
| Jan 20, 22 | Carl L GordonDirector,TenPercentOwner | BUY | 35.0K | $9.95 | $348K |
| Jan 20, 22 | Orbimed Capital Gp VII LlcDirector,TenPercentOwner | BUY | 35.0K | $9.95 | $348K |
| Jan 19, 22 | Carl L GordonDirector,TenPercentOwner | BUY | 11.5K | $9.97 | $115K |
| Jan 19, 22 | Orbimed Capital Gp VII LlcDirector,TenPercentOwner | BUY | 11.5K | $9.97 | $115K |
| Jan 13, 22 | Carl L GordonDirector,TenPercentOwner | BUY | 17.3K | $9.43 | $163K |
| Jan 13, 22 | Orbimed Capital Gp VII LlcDirector,TenPercentOwner | BUY | 17.3K | $9.43 | $163K |
| Jan 12, 22 | Carl L GordonDirector,TenPercentOwner | BUY | 18.9K | $10.06 | $190K |
| Jan 12, 22 | Orbimed Capital Gp VII LlcDirector,TenPercentOwner | BUY | 18.9K | $10.06 | $190K |
| Jan 11, 22 | Carl L GordonDirector,TenPercentOwner | BUY | 6.9K | $10.67 | $74K |
| Jan 11, 22 | Orbimed Capital Gp VII LlcDirector,TenPercentOwner | BUY | 6.9K | $10.67 | $74K |
| Dec 21, 21 | Timothy P ClacksonPresident and CEO | BUY | 2.6K | $9.76 | $25K |
| Dec 21, 21 | Bradford D. DahmsChief Financial Officer | BUY | 2.0K | $10.15 | $20K |
| Oct 12, 21 | Carl L GordonDirector,TenPercentOwner | BUY | 562.5K | $16.00 | $9.0M |
| Oct 12, 21 | Orbimed Genesis Gp LlcTenPercentOwner | BUY | 562.5K | $16.00 | $9.0M |
| Oct 12, 21 | Anne-mari PasterOther | BUY | 187.5K | $16.00 | $3.0M |
| Oct 12, 21 | Rock Springs Capital LlcTenPercentOwner | BUY | 250.0K | $16.00 | $4.0M |
| Oct 12, 21 | William ShakespeareSee Remarks | BUY | 625 | $16.00 | $10K |
Over the past 12 months, insiders at Theseus Pharmaceuticals, Inc. filed 0 open-market purchases worth $0 and 0 sales worth $0 on THRX, which makes them mixed over the period. The most recent Form 4 was filed on .
The largest recent open-market THRX insider purchase in our data was $9.0M by Carl L Gordon, Director,TenPercentOwner, filed on Oct 12, 21.
0 different insiders at Theseus Pharmaceuticals, Inc. filed open-market SEC Form 4 transactions on THRX over the last 12 months.
InsiderTape plots every THRX insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Theseus Pharmaceuticals, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →